David Lemus

Business address
C/O Sorrento Therapeutics, Inc., 4955 Director's Place, San Diego, CA, 92121
Top holdings (ownership)
SCLX
Get insider transactions for this reporting owner
David Lemus has filed 13 SEC EDGAR filings since 02 Oct 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 06 Jan 2026 02 Jan 2026 001-39487
4 Open Document Open Filing 06 Jan 2025 02 Jan 2025 001-39487
3 Open Document Open Filing 02 Jan 2025 02 Jan 2025 001-39487
4 Open Document Open Filing 4 18 Oct 2024 17 Oct 2024 001-39852
4 Open Document Open Filing 4 26 Jun 2024 15 Mar 2024 001-39852
4 Open Document Open Filing FORM 4 SUBMISSION 17 Jan 2023 17 Jan 2023 001-39852
3 Open Document Open Filing FORM 3 SUBMISSION 15 Nov 2022 10 Nov 2022 001-39852
4 Open Document Open Filing FORM 4 SUBMISSION 30 Aug 2021 30 Aug 2021 001-36150
4 Open Document Open Filing FORM 4 15 Jun 2020 15 Jun 2020 001-36150
4 Open Document Open Filing FORM 4 23 Apr 2019 19 Apr 2019 001-36150
4 Open Document Open Filing FORM 4 27 Nov 2018 26 Nov 2018 001-36150
4 Open Document Open Filing OWNERSHIP DOCUMENT 16 Nov 2017 14 Nov 2017 001-36150
3 Open Document Open Filing OWNERSHIP DOCUMENT 02 Oct 2017 26 Sep 2017 001-36150